Denali Therapeutics (NASDAQ:DNLI) Earnings Information
Denali Therapeutics last released its quarterly earnings data on November 6th, 2019. The reported ($0.48) EPS for the quarter, beating the consensus estimate of ($0.56) by $0.08. The company had revenue of $13.60 million for the quarter, compared to the consensus estimate of $10.86 million. Denali Therapeutics has generated ($0.39) earnings per share over the last year. Denali Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 10th, 2020 based off prior year's report dates.
Denali Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Denali Therapeutics (NASDAQ:DNLI) Earnings Estimates
2019 EPS Consensus Estimate: ($1.31)
2020 EPS Consensus Estimate: ($2.62)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q3 2019 | 1 | ($0.64) | ($0.64) | ($0.64) |
| Q4 2019 | 1 | ($0.67) | ($0.67) | ($0.67) |
| Q1 2020 | 1 | ($0.65) | ($0.65) | ($0.65) |
| Q2 2020 | 1 | ($0.65) | ($0.65) | ($0.65) |
| Q3 2020 | 1 | ($0.78) | ($0.78) | ($0.78) |
| Q4 2020 | 1 | ($0.54) | ($0.54) | ($0.54) |
Denali Therapeutics (NASDAQ DNLI) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
3/10/2020
(Estimated) | | | | | | | | |
| 11/6/2019 | Q3 | ($0.5630) | ($0.48) | ($0.48) | $10.86 million | $13.60 million | N/A | |
| 8/6/2019 | Q2 2019 | ($0.46) | ($0.61) | ($0.61) | $4.52 million | $4.20 million | N/A | |
| 5/8/2019 | Q1 | ($0.4030) | ($0.41) | ($0.41) | $12.88 million | $4.21 million | N/A | |
| 3/12/2019 | 12/31/2018 | ($0.11) | $0.79 | $0.79 | $9.73 million | $125.68 million | N/A | |
| 11/8/2018 | Q3 | ($0.2530) | ($0.38) | ($0.38) | $3.00 million | $1.20 million | N/A | |
| 8/9/2018 | Q2 2018 | ($0.2030) | ($0.59) | ($0.59) | $3.00 million | $1.65 million | N/A | |
| 5/11/2018 | Q1 2018 | $0.13 | ($0.26) | ($0.26) | $45.00 million | $0.64 million | N/A | |
| 3/19/2018 | Q4 2017 | ($0.2720) | ($0.74) | ($0.74) | | | N/A | |
(Earnings results data provided by Zacks Investment Research)
